首页 News 正文

Oral smeglutide is approved to be marketed in China for the treatment of type 2 diabetes

阿豆学长长ov
218 0 0

On January 26, the information released by the National Drug Administration (NMPA) showed that Smeaglutide Tablets under Novo Nordisk (China) Pharmaceutical Co., Ltd. was approved for listing to treat type 2 diabetes. This is the first domestically approved oral GLP-1 (glucagon like peptide-1) receptor agonist.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

阿豆学长长ov 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    27